Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle

被引:47
作者
Ha, EJ [1 ]
Smith, AM [1 ]
机构
[1] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA
关键词
selenium; glutathione peroxidase; estrogen; menstrual cycle; nutritional status;
D O I
10.1080/07315724.2003.10719274
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: This study was designed to determine the timing and magnitude of changes in selenium status in relation to the fluctuation of 17-beta-estradiol during the-menstrual cycle and the effect of different phases of the menstrual cycle on dietary selenium intake. Methods:Plasma 17-beta-estradiol and plasma and erythrocyte selenium and glutathione peroxidase (GPx) activity were measured in fasting blood samples collected in the morning at four times over three phases of the menstrual cycle: early follicular (EF: days 1-3 menstruation), periovulatory (PO; E-1:1 day before estrogen peak and E: during estrogen peak) and mid-luteal (ML: 7-9 days after ovulation) in healthy women (n = 14) aged 21 to 39 years and with regular menstrual cycles (26 to 30 days). The estrogen peak was confirmed by measurement of the luteinizing hormone surge. Dietary records (three-day) coincided with blood collection for each phase. Results:Plasma selenium and plasma and erythrocyte GPx activity were greatest during the periovulatory phase, coinciding with the estrogen peak. No differences were observed for erythrocyte selenium or dietary selenium throughout the cycle. A linear relationship existed between estradiol and plasma selenium (p < 0.0027), plasma GPx activity (p < 0.0001), and erythrocyte GPx activity (P < 0.0001). Conclusions: These results indicate that blood selenium parameters fluctuate during the menstrual cycle such that the phase of the cycle should be considered when assessing selenium status.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 50 条
[21]  
Koh T, 1982, J ASSOC OFF ANA CHEM, V66
[22]   Variation in risk indicators of cardiovascular disease during the menstrual cycle: An investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women [J].
Larsen, LF ;
Andersen, HR ;
Hansen, AB ;
Andersen, O .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (03) :241-249
[23]   BIOAVAILABILITY OF SELENIUM TO FINNISH MEN AS ASSESSED BY PLATELET GLUTATHIONE-PEROXIDASE ACTIVITY AND OTHER BLOOD PARAMETERS [J].
LEVANDER, OA ;
ALFTHAN, G ;
ARVILOMMI, H ;
GREF, CG ;
HUTTUNEN, JK ;
KATAJA, M ;
KOIVISTOINEN, P ;
PIKKARAINEN, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1983, 37 (06) :887-897
[24]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[25]  
MARANO G, 1991, J TRACE ELEM ELECT H, V5, P59
[26]   Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women [J].
Massafra, C ;
Buonocore, G ;
Gioia, D ;
Sargentini, I ;
Farina, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :173-175
[27]   Changes in the erythrocyte antioxidant enzyme system during transdermal estradiol therapy for secondary amenorrhea [J].
Massafra, C ;
Buonocore, G ;
Gioia, D ;
Sargentini, I .
GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (03) :155-158
[28]   ANTIOXIDANT ERYTHROCYTE ENZYME-ACTIVITIES DURING ORAL CONTRACEPTION [J].
MASSAFRA, C ;
BUONOCORE, G ;
BERNI, S ;
GIOIA, D ;
GIULIANI, A ;
VEZZOSI, P .
CONTRACEPTION, 1993, 47 (06) :591-596
[29]   Variations in erythrocyte antioxidant glutathione peroxidase activity during the menstrual cycle [J].
Massafra, C ;
De Felice, C ;
Gioia, D ;
Buonocore, G .
CLINICAL ENDOCRINOLOGY, 1998, 49 (01) :63-67
[30]  
MCADAM PA, 1994, FASEB J, V8, pA436